![]() | |
Clinical data | |
---|---|
Trade names | Altinil |
Other names | Thiazesim; Thiazenone; SQ-10496 |
Routes of administration | By mouth |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChemCID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C19H22N2OS |
Molar mass | 326.46 g·mol−1 |
3D model (JSmol) | |
| |
|
Tiazesim (INNTooltip International Nonproprietary Name), orthiazesim (BANTooltip British Approved Name,USANTooltip United States Adopted Name), previously sold under the brand nameAltinil, is aheterocyclicantidepressant related to thetricyclic antidepressants (TCAs) which, introduced in 1966 by Squibb Corporation (nowBristol-Myers Squibb), has since been discontinued and is no longer marketed.[1][2]
![]() | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |